Fig 6From: Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteersModel validation and raw data of pharmacodynamic variables for IFN gamma. Legend: Data correspond to the nine healthy male subjects who received 24.5 × 106 IU of CIGB-128-A at time 0. a Neopterin. b β2M. c 2′–5′ OAS1 and (d) Body temperature (first 48 h). Raw data is plotted together with VPC graphBack to article page